Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bayer acquires antibody license from MorphoSys

Jan. 15, 2003

Aventis to develop novel cancer targets under Eos collaboration

Jan. 15, 2003

Three series of telomerase inhibitors recently presented by Kyowa Hakko

Jan. 15, 2003

Purdue licenses Corixa antigen

Jan. 14, 2003

Novel apoptosis inhibitors with utility in cancer and other disorders

Jan. 14, 2003

Ariad files IND for AP-23573

Jan. 13, 2003

Iressa review by the FDA will take more time than anticipated

Jan. 13, 2003

New TGF-beta antagonists for cancer and other uses covered by Lilly patent

Jan. 13, 2003

Protein kinase inhibitors discovered by Schering scientists

Jan. 13, 2003

Allos Therapeutics further expands oncology development pipeline

Jan. 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...